三级aa视频在线观看-三级国产-三级国产精品一区二区-三级国产三级在线-三级国产在线

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

New US drugs improve health

By Wang Xiaodong | China Daily | Updated: 2018-05-19 14:21
Share
Share - WeChat
An employee stacks Johnson& Johnson Neosporin brand boxes on the production line at the J&J consumer healthcare products plant in Lititz, Pennsylvania, the United States. [Photo/Agencies]

New drugs developed by pharmaceutical companies from the United States have played an important role in improving healthcare for Chinese, according to China Association of Enterprises with Foreign Investment.

International pharmaceutical companies, including those from the US, have kept investing in research and development of new drugs in China, which has also contributed to improved innovation and research capabilities for domestic pharmaceutical companies, said Zuo Yuzeng, chief for communications at the association's R& D-based Pharmaceutical Association Committee.

The committee is comprised of 40 international companies with pharmaceutical research and development capabilities, including 12 from the US, such as MSD and Xian Janssen, he said.

"The companies have brought many patent drugs to Chinese patients. Many were not available in China before, and have contributed to helping patients relieve pain and prolong life," the committee said.

A recent new drug that was introduced to China was Sirturo, developed by Xian Janssen Pharmaceutical, a subsidiary of US company Johnson& Johnson.

The drug, the first new medication for tuberculosis worldwide for the past 45 years, has been administered in China since Feb 24, and initial results showed it is effective for patients with multidrug-resistant TB, according to Wang Bin, deputy head of disease control and prevention for the National Health Commission.

Asgar Rangoonwala, president of Xian Janssen, said the drug is now being used at 16 hospitals nationwide in a trial program.

In April, China Drug Administration approved a nine-way HPV vaccine, which works against up to nine types of HPV and was developed by US company MSD. A similar vaccine, which was also developed by the company and works against four types of HPV, was approved by the administration in May last year.

Previously, no vaccines were available on the Chinese mainland to effectively prevent cervical cancer, the second most common cancer among Chinese women aged 15 to 44 after breast cancer, except a two-way HPV vaccine, driving many women to Hong Kong to receive such vaccines.

International pharmaceutical companies have also contributed to improved capacities in innovation and research of domestic companies through increasing research and development in China, partnering with domestic research institutes and providing training, according to R & D-based Pharmaceutical Association Committee.

"Some domestic international companies in recent years have been developing fast and they are catching up," said Zuo from the committee.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 成人在线网站 | 欧美视频第一区 | 成人在线播放av | 精品免费视在线视频观看 | 国产性精品 | 精品视频国产 | 免费国产阿v视频在线观看 免费国产高清精品一区在线 | 99热在线获取最新地址 | 国产 日韩 欧美 在线 | 精品国产麻豆 | 99re热久久 | 免费国产成人高清在线观看视频 | 国内在线网友露脸自拍 | 91精品免费观看老司机 | 欧美成人黑人xx视频免费观看 | 激情91| 182福利视频在线观看黄 | 一区二区福利 | 扒开双腿猛进入jk校视频 | 中国日本欧美韩国18 | 国产精品综合视频 | 成年网站在线观看视频 | 精品国产一区二区二三区在线观看 | 亚洲综合色视频 | 成人久久免费视频 | 久久国产精品影院 | 国产精品人成 | 香蕉久久久久 | 国产女人伦码一区二区三区不卡 | 中出欧美 | 青青青亚洲精品国产 | 国产精品入口麻豆免费 | 亚色中文字幕 | 日韩版码免费福利视频 | 免费中国女人69xxxxx视频 | 中文字幕免费在线观看动作大片 | 在线视频一区二区日韩国产 | 1300部小u女视频免费 | 最近免费中文在线视频 | 久久精品视频2 | 国产综合色在线视频 |